A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients

The requested reference [13cb904dc562a5dfb008e961f85b96bfe9ae805a] no longer exists in our database. It has been replaced by the current reference: [c67c4d86e023960b324671a7c74a9a936bb57ef4]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in intracerebral hemorrhage patients.
Epistemonikos ID: 5a518f465a57b051d2ef00109468685c6052a045
First added on: May 11, 2024